Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23013270)

  • 1. Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL.
    Hernandez-Luna MA; Rocha-Zavaleta L; Vega MI; Huerta-Yepez S
    Leuk Lymphoma; 2013 May; 54(5):1048-55. PubMed ID: 23013270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
    Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B
    J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL-xL is a target gene regulated by hypoxia-inducible factor-1{alpha}.
    Chen N; Chen X; Huang R; Zeng H; Gong J; Meng W; Lu Y; Zhao F; Wang L; Zhou Q
    J Biol Chem; 2009 Apr; 284(15):10004-12. PubMed ID: 19211554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of HIF-1α and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells.
    Choi SH; Park JY; Kang W; Kim SU; Kim do Y; Ahn SH; Ro SW; Han KH
    Apoptosis; 2016 Jan; 21(1):85-95. PubMed ID: 26467924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of hypoxia-inducible factor-1α are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma.
    Chen C; Zhou H; Wei F; Jiang L; Liu X; Liu Z; Ma Q
    J Orthop Res; 2011 Jan; 29(1):143-51. PubMed ID: 20661931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC.
    Pang YY; Wang T; Chen FY; Wu YL; Shao X; Xiao F; Huang HH; Zhong H; Zhong JH
    Leuk Lymphoma; 2015 Jun; 56(6):1821-30. PubMed ID: 25219592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells.
    Zou J; Li P; Lu F; Liu N; Dai J; Ye J; Qu X; Sun X; Ma D; Park J; Ji C
    J Hematol Oncol; 2013 Jan; 6():3. PubMed ID: 23289374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells.
    Xu S; Yu C; Ma X; Li Y; Shen Y; Chen Y; Huang S; Zhang T; Deng W; Wang Y
    Eur J Pharmacol; 2021 Mar; 894():173817. PubMed ID: 33345849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
    Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
    Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α.
    Ao Q; Su W; Guo S; Cai L; Huang L
    Sci Rep; 2015 Nov; 5():16396. PubMed ID: 26548925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
    Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
    Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.
    McEvoy LM; O'Toole SA; Spillane CD; Martin CM; Gallagher MF; Stordal B; Blackshields G; Sheils O; O'Leary JJ
    BMC Cancer; 2015 Jul; 15():547. PubMed ID: 26205780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha.
    Adamski J; Price A; Dive C; Makin G
    PLoS One; 2013; 8(6):e65304. PubMed ID: 23785417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
    Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
    Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cycling hypoxia induces chemoresistance through the activation of reactive oxygen species-mediated B-cell lymphoma extra-long pathway in glioblastoma multiforme.
    Chen WL; Wang CC; Lin YJ; Wu CP; Hsieh CH
    J Transl Med; 2015 Dec; 13():389. PubMed ID: 26711814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1α expression.
    Min L; Chen Q; He S; Liu S; Ma Y
    Mol Med Rep; 2012 Jan; 5(1):228-32. PubMed ID: 21964646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
    Villedieu M; Louis MH; Dutoit S; Brotin E; Lincet H; Duigou F; Staedel C; Gauduchon P; Poulain L
    Gynecol Oncol; 2007 Apr; 105(1):31-44. PubMed ID: 17275076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.